Opsonix opsonix.com


Public lists: Pharma Startups (6570)

Opsonix is developing pathogen-extracting therapies to transform the treatment of blood borne infectious diseases, including sepsis. The company's proprietary expertise is creating engineered pathogen-capture proteins derived from opsonins, which are natural components of our innate immune system that bind all types of infectious invaders and toxins, and thereby enable their clearance from our bodies. Opsonix's lead pathogen-capture protein, FcMBL, is being developed as an extracorporeal therapy...Show all

Opsonix is developing pathogen-extracting therapies to transform the treatment of blood borne infectious diseases, including sepsis. The company's proprietary expertise is creating engineered pathogen-capture proteins derived from opsonins, which are...Show all

Company (Alive / Active)

Phone: 508 351 2902

Fax:

301 Edgewater Place
Suite 10
Wakefield, 01880
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Opsonix $9.3M Nov 8, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Opsonix Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 3 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)